title: Differential alterations of kainate receptor subunits in inhibitory interneurons in the anterior cingulate cortex in schizophrenia and bipolar disorder.
abstract: The aim of this study was to examine whether glutamatergic inputs onto GABA interneurons via the kainate receptor in the anterior cingulate cortex may be altered in schizophrenia and bipolar disorder. Hence, in a cohort of 60 post-mortem human brains from schizophrenia, bipolar disorder, and normal control subjects, we simultaneously labeled the mRNA for the GluR5 or GluR6 subunit of the kainate receptor with [(35)S] and the mRNA for the 67 kD isoform of the GABA synthesizing enzyme glutamic acid decarboxylase (GAD)(67) with digoxigenin using an immunoperoxidase method. The density of the GAD(67) mRNA-containing neurons that co-expressed GluR5 mRNA was decreased by 43% and 40% in layer 2 of the anterior cingulate cortex in schizophrenia and bipolar disorder, respectively. In contrast, the density of the GAD(67) mRNA-containing cells that expressed GluR6 mRNA was unaltered in either condition. Furthermore, the amount of GluR5 or GluR6 mRNA in the GAD(67) mRNA-expressing cells that contained a detectable level of these transcripts was also unchanged. Finally, the density of cells that did not contain GAD(67) mRNA, which presumably included all pyramidal neurons, but expressed the mRNA for the GluR5 or GluR6 subunit was not altered. Thus, glutamatergic modulation of inhibitory interneurons, but not pyramidal neurons, via kainate receptors containing the GluR5 subunit appears to be selectively altered in the anterior cingulate cortex in schizophrenia and bipolar disorder.
authors: Program in Structural and Molecular Neuroscience, McLean Hospital, Belmont, MA 02478, USA.
authors: Tsung-Ung W
authors: TU
authors: Woo
authors: Kevin
authors: K
authors: Shrestha
authors: Christopher
authors: C
authors: Amstrong
authors: Martin M
authors: MM
authors: Minns
authors: John P
authors: JP
authors: Walsh
authors: Francine M
authors: FM
authors: Benes
mesh_terms: D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001706:Biopsy; D001714:Bipolar Disorder / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D002648:Child; D005260:Female; D007839:Functional Laterality; D006179:Gyrus Cinguli / Q000033:anatomy & histology / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D008297:Male; D021122:Protein Subunits / Q000378:metabolism; D018092:Kainic Acid Receptors / Q000378:metabolism*; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology
chemical_list: D014150:Antipsychotic Agents; D021122:Protein Subunits; D018092:Kainic Acid Receptors
references: Arch Gen Psychiatry. 2004 Jul;61(7):649-57
references: 15237077
references: Clin Neurophysiol. 2004 Aug;115(8):1863-74
references: 15261865
references: Schizophr Res. 2004 Oct 1;70(2-3):293-302
references: 15329305
references: Nat Rev Neurosci. 2004 Oct;5(10):793-807
references: 15378039
references: Biochem Pharmacol. 2004 Oct 15;68(8):1507-14
references: 15451393
references: J Neurosci. 2004 Oct 13;24(41):8986-93
references: 15483117
references: Arch Gen Psychiatry. 1972 Jan;26(1):57-63
references: 5009428
references: Arch Gen Psychiatry. 1986 Jan;43(1):31-5
references: 3942472
references: Arch Gen Psychiatry. 1995 Dec;52(12):998-1007
references: 7492260
references: Curr Opin Neurobiol. 2001 Jun;11(3):327-35
references: 11399431
references: Neurosci Lett. 1995 Nov 24;200(3):151-4
references: 9064599
references: Psychiatry Res. 1995 Nov 29;59(1-2):81-96
references: 8771223
references: Neuroscience. 1996 Dec;75(4):1021-31
references: 8938738
references: Biol Psychiatry. 1997 Mar 15;41(6):636-43
references: 9066986
references: J Neurosci. 1997 May 15;17(10):3894-906
references: 9133407
references: Nature. 1997 Jul 10;388(6638):179-82
references: 9217158
references: Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5341-6
references: 9560277
references: Science. 1998 May 1;280(5364):747-9
references: 9563953
references: J Neurosci. 1999 Jan 15;19(2):653-63
references: 9880586
references: Nat Neurosci. 1998 Oct;1(6):470-8
references: 10196544
references: J Neurophysiol. 1999 Apr;81(4):1903-16
references: 10200225
references: Brain Res Mol Brain Res. 1999 Aug 25;71(2):201-9
references: 10521574
references: Schizophr Res. 2005 Feb 1;73(1):79-89
references: 15567080
references: Crit Rev Neurobiol. 2004;16(1-2):1-23
references: 15581395
references: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17288-93
references: 15546988
references: J Physiol. 2005 Jan 1;562(Pt 1):65-72
references: 15513934
references: Nat Rev Neurosci. 2005 Apr;6(4):312-24
references: 15803162
references: Neuropsychopharmacology. 2005 Aug;30(8):1521-31
references: 15886719
references: Am J Psychiatry. 2005 Dec;162(12):2330-6
references: 16330598
references: J Neurosci. 2006 Feb 1;26(5):1604-15
references: 16452684
references: Mol Psychiatry. 2006 Mar;11(3):241-51
references: 16288314
references: J Neurosci. 2006 Mar 8;26(10):2767-76
references: 16525056
references: J Neurosci. 2006 Aug 2;26(31):8168-75
references: 16885230
references: Exp Brain Res. 2006 Aug;173(2):234-42
references: 16505999
references: Biol Psychiatry. 2006 Dec 1;60(11):1231-40
references: 16893524
references: Pharmacopsychiatry. 2003 Nov;36(6):292-6
references: 14663653
references: Arch Gen Psychiatry. 1999 Nov;56(11):1001-5
references: 10565499
references: J Psychiatr Res. 1999 Nov-Dec;33(6):523-33
references: 10628529
references: J Neurosci. 2000 Jan 1;20(1):196-205
references: 10627597
references: Science. 2000 Jan 14;287(5451):273-8
references: 10634775
references: Brain Res Brain Res Rev. 2000 Mar;31(2-3):251-69
references: 10719152
references: Clin Neurophysiol. 2000 Aug;111(8):1461-8
references: 10904228
references: Brain Res Bull. 2000 Jul 15;52(5):319-30
references: 10922509
references: Neuron. 2000 Nov;28(2):475-84
references: 11144357
references: J Chem Neuroanat. 2000 Dec;20(3-4):259-69
references: 11207424
references: Clin Neuropharmacol. 2001 Jan-Feb;24(1):43-9
references: 11290881
references: J Neurosci. 2001 May 15;21(10):3646-55
references: 11331394
references: Arch Gen Psychiatry. 1991 Nov;48(11):996-1001
references: 1747023
references: J Neurosci. 1992 Mar;12(3):924-9
references: 1372045
references: J Mol Neurosci. 1993 Winter;4(4):263-75
references: 7917835
references: Brain. 1995 Feb;118 ( Pt 1):279-306
references: 7895011
references: Brain Res Mol Brain Res. 1995 Feb;28(2):311-8
references: 7723629
references: Brain Res. 1995 Mar 13;674(1):82-90
references: 7773698
references: Neuropsychopharmacology. 2001 Jul;25(1):1-27
references: 11377916
references: Nat Rev Neurosci. 2001 Jun;2(6):417-24
references: 11389475
references: Ann N Y Acad Sci. 2001 May;935:107-17
references: 11411161
references: Science. 2001 Aug 10;293(5532):1159-63
references: 11498596
references: Am J Psychiatry. 2001 Sep;158(9):1423-8
references: 11532726
references: Biol Psychiatry. 2001 Sep 15;50(6):395-406
references: 11566156
references: Brain Res Bull. 2001 Jul 15;55(5):569-78
references: 11576753
references: Brain Res Bull. 2001 Jul 15;55(5):579-84
references: 11576754
references: Nat Neurosci. 2002 Feb;5(2):175-80
references: 11802172
references: Biol Psychiatry. 2002 Mar 1;51(5):377-86
references: 11904132
references: Acta Neurobiol Exp (Wars). 2001;61(4):309-18
references: 11905152
references: Biol Psychiatry. 2002 Oct 1;52(7):708-15
references: 12372661
references: Neuropsychopharmacology. 2002 Nov;27(5):826-33
references: 12431856
references: Nat Rev Neurosci. 2003 Jun;4(6):481-95
references: 12778120
references: Biol Psychiatry. 2003 Jun 15;53(12):1086-98
references: 12814860
references: J Neurosci. 2003 Jul 16;23(15):6315-26
references: 12867516
references: Am J Psychiatry. 2003 Dec;160(12):2238-40
references: 14638599
references: Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1368-73
references: 14742867